Nav: Home

Outwitting the 'silent thief' of osteoporosis

October 13, 2016

In a world first, new Australian research has revealed that genetic profiling can help predict whether an individual will break a bone through osteoporosis. The findings, which arise from Australia's globally-recognised Dubbo Osteoporosis Epidemiology Study, are likely to contribute to clinical decision-making in future, bringing us one step closer to personalised medicine for bone disease.

Osteoporosis - brittle, weakened bones - affects 1.2 million Australians and causes more than 150,000 fractures per year in Australia. Osteoporosis and associated fractures represent a major national public health problem, costing the health system billions of dollars per year (total cost estimated at $33.6 billion for 2012-2022) - and with the demographic tsunami of aging upon us, the scale of Australia's osteoporosis problem will continue to rise.

Osteoporosis is dubbed 'the silent thief', because bone loss occurs without obvious symptoms until a bone is broken. Because of the silent nature of osteoporosis, it is very difficult to predict who will or will not fracture. For this reason, one key goal of osteoporosis research is to identify those who have a high risk of breaking a bone - with the ultimate aim of preventing avoidable fractures.

Professor Tuan Nguyen (Garvan Institute of Medical Research and University of Technology Sydney) led the new research. He explains, "Our study shows, for the first time, that we can classify an individual's risk of breaking a bone much more reliably when we take genetic factors into account alongside clinical factors.

"This is a major step towards personalised medicine for osteoporosis.

Prof Nguyen says the findings overturn long-held skepticism in the bone health field about the role of genetics in the clinical management of osteoporosis.

"We have known for many years that a number of genetic variants are linked to low bone density and to fracture - but until now, we have struggled to transform that knowledge into clinical benefit to patients," Prof Nguyen says.

"It has previously been difficult to see how genetic variation might become clinically important, because the effect of each individual genetic variant on fracture risk is very subtle.

"To overcome this issue, we looked at 62 different genetic variants in tandem across over 1400 individuals in the Dubbo study - and we found that, together, those variants become a powerful predictive tool.

"Once we have validated our findings in other populations, we will be looking to develop a cost-effective gene profiling test that will be available for clinicians to use. The test will determine a 'genetic risk score' on the basis of a blood sample, which contains ample DNA for profiling."

The new findings arise from Garvan's leading Dubbo Osteoporosis Epidemiology Study, the world's largest and longest running population-based study of osteoporosis in men and women. The Dubbo Study has been gathering broad-ranging health data, including bone health and genomic information, from thousands of residents of Dubbo, NSW for 27 years.

Among other major contributions to our understanding of osteoporosis, the Dubbo Study has enabled the development of the Garvan Fracture Risk Calculator (GFRC), one of two major algorithms worldwide that is used clinically to determine an individual's risk of osteoporotic fracture. The GFRC uses clinical risk factors (age, sex, history of falls and fractures, and bone density) to assess an individual's fracture risk.

Importantly, the new findings now show that genetic profiling further improves the accuracy of the GFRC.

Each of the genetic variants studied by the researchers is a single-nucleotide polymorphism, or SNP - a site at which the DNA code is altered by a single 'letter' or nucleotide in some individuals, and where one 'letter' is more commonly found in individuals with higher fracture risk. The researchers used each study participant's SNP profile to generate a personalised 'genetic risk score'.

For each of the 1400+ individuals studied, the researchers looked at whether a bone had been broken over a 10-year period. They then assessed whether the GFRC had correctly predicted the risk of fracture - and whether the use of the 'genetic risk score' could improve the accuracy of the GFRC's prediction.

The result? A more accurate prediction of fracture risk. The researchers found that, when the 'genetic risk score' was used with the GFRC, the correct classification of individuals as high or low fracture risk was increased by 12% over and above that of the traditional clinical risk factors, which together correctly classify up to 80% of the studied individuals into high and low risk categories.

Professor John Eisman (Garvan), who heads the Dubbo study, says the findings, and their clinical relevance, are heartening.

"Each time we improve our understanding of the risk of bone fracture in osteoporosis, we are taking a step towards easier and more straightforward clinical decision-making for Australian GPs and Australian people - and in turn towards better outcomes for the 1.2 million Australians living with osteoporosis."

Professor John Mattick, Executive Director of Garvan, adds, "Once individual genome sequences become a routine part of medical records, this genetic risk information will be readily available and be used to optimise the management of health in older people."

The research has recently been accepted for publication in the Journal of Bone and Mineral Research, the premier journal in bone biology internationally.
-end-
Media enquiries: Dr Meredith Ross, Garvan - +61 (0) 439 873 258 - m.ross@garvan.org.au

Garvan Institute of Medical Research

Related Osteoporosis Articles:

Mind the (osteoporosis treatment) gap!
A new review, referencing key clinical studies, guidelines and audits, outlines the main global challenges (and their solutions) facing healthcare professionals and policymakers responsible for providing care to populations in relation to bone health and fracture prevention.
Outwitting the 'silent thief' of osteoporosis
In a world first, new Australian research has revealed that genetic profiling can help predict whether an individual will break a bone through osteoporosis.
Osteoporosis: Antibody crystallized
Inhibiting a protein called Sclerostin could probably help treating the bone-loss disease osteoporosis.
JBMR perspective: A crisis in the treatment of osteoporosis
The remarkable progress made over the past 30 years to reduce fractures and dramatically improve the quality of life for millions of osteoporosis patients is rapidly being reversed, say two bone health experts in a Journal of Bone and Mineral Research article published online today.
The developmental origins of osteoporosis
Osteoporosis may have its origins in early life, but the consequences are not apparent until late adult life.
Task force provides guidance on use of osteoporosis drugs
A new report by a task force of the American Society for Bone and Mineral Research provides guidance on the use of bisphosphonates, which are the most commonly used medications for osteoporosis.
Whole genome-sequencing uncovers new genetic cause for osteoporosis
Using one of the world's most extensive genetics data sets, an international research team led by Dr.
Men far less likely to prevent, screen for osteoporosis
While the consequences of osteoporosis are worse in men than women -- including death -- older males are far less likely to take preventive measures against the potentially devastating bone-thinning disease or accept recommendations for screening, according to startling new research by North Shore-LIJ Health System geriatricians.
'Aquatic osteoporosis' jellifying lakes
North American lakes are suffering from declining calcium levels, says new research from Queen's University.
Osteoporosis, not just a woman's disease
While osteoporosis prevention and treatment efforts have historically been focused on post-menopausal women, a new study from Beth Israel Deaconess Medical Center suggests that critical opportunities are being lost by not focusing more attention on bone loss and fracture risk in older men.

Related Osteoporosis Reading:

Dr. Lani's No-Nonsense Bone Health Guide: The Truth About Density Testing, Osteoporosis Drugs, and Building Bone Quality at Any Age
by Lani Simpson DC CCD (Author), Claude Arnaud MD FACE (Foreword)

The Whole-Body Approach to Osteoporosis: How to Improve Bone Strength and Reduce Your Fracture Risk (The New Harbinger Whole-Body Healing Series)
by R. Keith McCormick (Author)

The Healthy Bones Nutrition Plan and Cookbook: How to Prepare and Combine Whole Foods to Prevent and Treat Osteoporosis Naturally
by Dr. Laura Kelly (Author), Helen Bryman Kelly (Author), Dr. Sidney MacDonald Baker (Foreword)

Exercise for Better Bones: The Complete Guide to Safe and Effective Exercises for Osteoporosis
by Margaret Martin (Author)

Yoga for Osteoporosis: The Complete Guide
by Loren Fishman MD (Author), Ellen Saltonstall MD (Author)

Lies My Doctor Told Me: Osteoporosis: How the Latest Medical Research on Bone Drugs and Calcium Could Save Your Bones, Your Heart, and Your Life (Volume 1)
by Harmony Clearwater Grace (Author)

The Osteoporosis Revolution

Mayo Clinic Guide to Preventing and Treating Osteoporosis
by MD Bart Clarke (Author)

Beat Osteoporosis with Exercise: A Low-Impact Program for Building Strength, Increasing Bone Density and Improving Posture
by Karl Knopf (Author)

Osteoporosis Diet: Your Complete Guide to Prevent and Reverse Bone Loss Using Natural Remedies, Diet and Exercise without Medication
by Kasia Dziurda RN (Author)

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Approaching With Kindness
We often forget to say the words "thank you." But can those two words change how you — and those around you — look at the world? This hour, TED speakers on the power of gratitude and appreciation. Guests include author AJ Jacobs, author and former baseball player Mike Robbins, Dr. Laura Trice, Professor of Management Christine Porath, and former Danish politician Özlem Cekic.
Now Playing: Science for the People

#509 Anisogamy: The Beginning of Male and Female
This week we discuss how the sperm and egg came to be, and how a difference of reproductive interest has led to sexual conflict in bed bugs. We'll be speaking with Dr. Geoff Parker, an evolutionary biologist credited with developing a theory to explain the evolution of two sexes, about anisogamy, sexual reproduction through the fusion of two different gametes: the egg and the sperm. Then we'll speak with Dr. Roberto Pereira, research scientist in urban entomology at the University of Florida, about traumatic insemination in bed bugs.